Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lynch

Showing results (1061-1070 of 1,148) with videos related to

Pageof 115
Sort By:
Neurology. Clinical Practice|August 30, 2023
Friedreich's Ataxia-Health Index: Development and Validation of a Novel Disease-Specific Patient-Reported Outcome MeasureJamison Seabury, Spencer Rosero, Anika Varma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2022
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe ExtensionDavid R Lynch, Melanie P Chin, Sylvia Boesch, et al.
Scientific Reports|June 20, 2015
MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancerYanli He, Lihui Wang, Weijun Liu, et al.
Annals of Clinical and Translational Neurology|September 11, 2023
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history dataDavid R Lynch, Angie Goldsberry, Christian Rummey, et al.
Annals of Neurology|October 17, 2020
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)David R Lynch, Melanie P Chin, Martin B Delatycki, et al.
Neurology|December 30, 2004
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteriaM K Bruno, M Hallett, K Gwinn-Hardy, et al.
Annals of Neurology|April 2, 2009
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationMeizan Lai, Ethan G Hughes, Xiaoyu Peng, et al.
Journal of Child Neurology|April 3, 2018
Impact of Mobility Device Use on Quality of Life in Children With Friedreich AtaxiaResham Ejaz, Shiyi Chen, Charles J Isaacs, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-<i>γ</i> 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.
Neurology. Clinical Practice|May 16, 2024
Friedreich Ataxia Caregiver-Reported Health Index: Development of a Novel, Disease-Specific Caregiver-Reported Outcome MeasureJamison Seabury, Anika Varma, Jennifer Weinstein, et al.
Pageof 115

Showing results (1061-1070 of 1,148) with videos related to

Sort By:
Pageof 115
Neurology. Clinical Practice|August 30, 2023
Friedreich's Ataxia-Health Index: Development and Validation of a Novel Disease-Specific Patient-Reported Outcome MeasureJamison Seabury, Spencer Rosero, Anika Varma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2022
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe ExtensionDavid R Lynch, Melanie P Chin, Sylvia Boesch, et al.
Scientific Reports|June 20, 2015
MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancerYanli He, Lihui Wang, Weijun Liu, et al.
Annals of Clinical and Translational Neurology|September 11, 2023
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history dataDavid R Lynch, Angie Goldsberry, Christian Rummey, et al.
Annals of Neurology|October 17, 2020
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)David R Lynch, Melanie P Chin, Martin B Delatycki, et al.
Neurology|December 30, 2004
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteriaM K Bruno, M Hallett, K Gwinn-Hardy, et al.
Annals of Neurology|April 2, 2009
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationMeizan Lai, Ethan G Hughes, Xiaoyu Peng, et al.
Journal of Child Neurology|April 3, 2018
Impact of Mobility Device Use on Quality of Life in Children With Friedreich AtaxiaResham Ejaz, Shiyi Chen, Charles J Isaacs, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-<i>γ</i> 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.
Neurology. Clinical Practice|May 16, 2024
Friedreich Ataxia Caregiver-Reported Health Index: Development of a Novel, Disease-Specific Caregiver-Reported Outcome MeasureJamison Seabury, Anika Varma, Jennifer Weinstein, et al.
Pageof 115